Recognition of Leadership and Vision in Punjab’s Sports Development Punjab Lawn Tennis Association (PLTA) Senior …
Read More »Eli Lilly weight loss drug cuts risk of developing diabetes in trial
Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with prediabetes compared with a placebo, according to initial results from a long-term study released Tuesday. The late-stage trial on tirzepatide, the active ingredient in the company’s weight loss injection Zepbound and diabetes drug Mounjaro, also found that …
Read More »